Clinical Trial Update: Characterization of Prostate Cancer With 3T MR

View source ↗

Summary

The document notes an ongoing clinical trial at Beth Israel Deaconess Medical Center using 3T MRI to characterize prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING